Budesonide Inhalation Suspension for Acute Asthma in Children

Completed · Phase 4 · Has a placebo group

Conditions studied: Asthma, Acute Asthma, Reactive Airway Exacerbation

In brief

The purpose of this study is to determine whether the addition of budesonide inhalation suspension (BIS) to the standard therapy of albuterol, ipratropium bromide, and systemic corticosteroids (SCS) for moderate to severe asthma flares in children reduces asthma severity more rapidly than standard therapy alone.

Key facts

Study ID
NCT00393367
Run by
Children's Hospital of Philadelphia
People needed
179
Starts
2006-12-01
Expected to finish
2007-11-01
Last updated by the study team
2012-08-10

Who can join

Age: 2 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.